-
EP4007762
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4007762
| EP4007762 - CONTINUOUS PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 06.05.2022 Database last updated on 15.07.2024 | |
| Former | The international publication has been made Status updated on 05.02.2021 | ||
| Former | unknown Status updated on 12.08.2020 | Most recent event Tooltip | 26.06.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Lexicon Pharmaceuticals, Inc. 2445 Technology Forest Blvd., Suite 1100 The Woodlands, TX 77381 / US | [2022/23] | Inventor(s) | 01 /
BUREL, Bruno c/o Sanofi Patent Department, 54, rue la Boétie 75008 Paris / FR | 02 /
CEZERAC, Jérome c/o Sanofi, Patent Department, 54, rue la Boétie 75008 Paris / FR | 03 /
DUTHEIL, Stéphane c/o Sanofi Patent Department, 54, rue la Boétie 75008 Paris / FR | 04 /
ETIENNE, Martial c/o Sanofi Patent Department, 54, rue la Boétie 75008 Paris / FR | 05 /
FLACHER, Richard c/o Sanofi, Patent Department, 54, rue la Boétie 75008 Paris / FR | 06 /
NOBREGA, Antonio c/o Sanofi, Patent Department, 54, rue la Boétie 75008 Paris / FR | [2022/23] | Representative(s) | Abel & Imray LLP Westpoint Building James Street West Bath BA1 2DA / GB | [2022/23] | Application number, filing date | 20750369.9 | 31.07.2020 | [2022/23] | WO2020IB57262 | Priority number, date | EP20190305998 | 01.08.2019 Original published format: EP 19305998 | [2022/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021019509 | Date: | 04.02.2021 | Language: | EN | [2021/05] | Type: | A1 Application with search report | No.: | EP4007762 | Date: | 08.06.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.02.2021 takes the place of the publication of the European patent application. | [2022/23] | Search report(s) | International search report - published on: | EP | 04.02.2021 | Classification | IPC: | C07H1/06, C07H7/04, C07H13/08, A61P3/10 | [2022/23] | CPC: |
C07H1/06 (EP,IL,US);
C07H13/08 (EP,IL,KR);
C07H7/04 (EP,IL,US);
A61P3/10 (EP,IL);
C07H1/00 (KR);
C07H15/14 (KR);
C07B2200/13 (KR,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/23] | Title | German: | KONTINUIERLICHES VERFAHREN ZUR HERSTELLUNG DER KRISTALLINEN FORM II VON SOTAGLIFLOZIN | [2022/23] | English: | CONTINUOUS PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN | [2022/23] | French: | PROCÉDÉ CONTINU POUR LA PRÉPARATION D'UNE FORME CRISTALLINE II DE SOTAGLIFLOZINE | [2022/23] | Entry into regional phase | 23.02.2022 | National basic fee paid | 23.02.2022 | Designation fee(s) paid | 23.02.2022 | Examination fee paid | Examination procedure | 23.02.2022 | Amendment by applicant (claims and/or description) | 23.02.2022 | Examination requested [2022/23] | 23.02.2022 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 15.06.2022 | Renewal fee patent year 03 | 14.06.2023 | Renewal fee patent year 04 | 26.06.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO2010009197 (LEXICON PHARMACEUTICALS INC [US], et al); | [A]WO2018067805 (TEVA PHARMA [IL], et al); | [A]EP3466958 (CRYSTAL PHARMACEUTICAL SUZHOU CO LTD [CN]); | by applicant | WO2010009197 |